Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Chimeric Antigen Receptor (CAR)-T cell Immunotherapy-Competitive Landscape 2015- DelveInsight ReportDelveInsight CAR-T cell therapy Report provides a comprehensive study of the pipeline drugs, acquisitions, collaborations & deals, licensing opportunities, competitor analysis and technologies being developed by biopharmaceutical firms
By: DelveInsight The Chimeric Antigen Receptor (CAR)-T cell Immunotherapy- Key Topics Covered: · Collaborations and Deals · Acquisitions · Licensing Opportunities · Pipeline Scenario and product profiles · CAR-T Technologies and Targeted Antigens · Adverse effects of CAR-T · Market Drivers and Barriers DelveInsight is offering the Report at a price of USD 1,750 as a single user license, USD 3,500 as a site license and USD 5,000 as a Global/Enterprise License. This Report will help to identify emerging players with potentially strong product information, licensing opportunities and helps you to create effective counter-strategies to gain competitive advantage. For more information on this report, email at info@delveInsight.com End
Account Email Address Account Phone Number Disclaimer Report Abuse Page Updated Last on: Jun 25, 2015
|
|